Literature DB >> 33832895

Design, Preparation and evaluation of various parameters of controlled release matrices of losartan potassium using polymers combination.

Kamran Ahmad Khan1, Gul Majid Khan2, Kifayat Ullah Shah1, Zahid Rasul Niazi1, Haroon Khan1, Ashfaq Ahmad3, Fazal -Ur-Rehman1, Pervaiz Akhtar Shah4, Aziz Ullah1, Muhammad Tahir1, Syed Umer Jan5.   

Abstract

Controlled release formulations are administered once a day and reduce frequency of dose and ensuring patient's compliance. In the current research controlled release matrices of losartan potassium formulated with polymeric combinations of ethocel grade 7 with carbopol 934P NF using different concentrations of polymers. In some polymeric tablets, Co-excipients like CMC, Starch, HPMC was added by replacing of 10% of filler in formulations at 10:5. Tablets were prepared by direct compression method and evaluated for physicochemical characteristics. USP Method-1 (rotating basket method) was used to carry out dissolution study in phosphate buffer pH 6.8. Drug release kinetics determined and comparison of dissolution patterns was done with reference tablets. The polymeric combinations well retarded drug release and drug was released by anamolous non-fickian diffusion mechanism. Dissolution profiles of tested tablets and reference tablets were found not similar. Drug release rate was increased by co-excipients. It was concluded from this research work that this polymeric combination can be used efficiently in designing of controlled release martices.

Entities:  

Year:  2020        PMID: 33832895

Source DB:  PubMed          Journal:  Pak J Pharm Sci        ISSN: 1011-601X            Impact factor:   0.684


  1 in total

1.  Preparation of Losartan Potassium Controlled Release Matrices and In-Vitro Investigation Using Rate Controlling Agents.

Authors:  Kamran Ahmad Khan; Gul Majid Khan; Muhammad Muzammal; Mohammed Al Mohaini; Abdulkhaliq J Alsalman; Maitham A Al Hawaj; Ashfaq Ahmad; Zahid Rasul Niazi; Kifayat Ullah Shah; Arshad Farid
Journal:  Molecules       Date:  2022-01-27       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.